Globally, tuberculosis (TB) remains a major cause of morbidity and mortality from infectious diseases. It poses a substantial public health challenge. According to the World Health Organization global report, TB was the leading cause of death from infectious disease in 2019 and the second leading cause in 2020 (after COVID‐19) [1, 2]. Among various forms of TB, musculoskeletal TB is particularly concerning. It accounts for 10%–15% of TB cases in developing nations [3]. This form of extrapulmonary TB (EPTB) often presents atypically, particularly in human immunodeficiency virus (HIV) coinfected patients, where it often manifests in areas outside the lungs, such as lymph nodes, pleura, and osteoarticular systems [4].